CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Creative Medical Technology Holdings, Inc. is a biotechnology company developing regenerative medicine and immunotherapy platforms for treating conditions in immunology, endocrinology, urogynecology, and orthopedics. The company's lead platform, ImmCelz, is a supercharged autologous immunotherapy that uses secreted factors from donor cells to reprogram patients' own immune cells, with clinical trials underway for type 1 diabetes and lower back pain.